We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.21%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.44B
AUM Growth
+$25.6M
(+0.47%)
Cap. Flow
+$82.4M
Cap. Flow
% of AUM
1.51%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
760
New
155
Increased
313
Reduced
140
Closed
45
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$51.9M |
| 2 |
Meta Platforms (Facebook)
META
|
+$42.1M |
| 3 |
TripAdvisor
TRIP
|
+$33.4M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$31.2M |
| 5 |
Methanex
MEOH
|
+$26.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LKQ Corp
LKQ
|
+$54.6M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$51.3M |
| 3 |
Amazon
AMZN
|
+$40.3M |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$39.9M |
| 5 |
Copa Holdings
CPA
|
+$38.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.2% |
| 2 | Consumer Discretionary | 15.8% |
| 3 | Industrials | 13.42% |
| 4 | Technology | 13.22% |
| 5 | Healthcare | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
MarketAxess Holdings
MKTX
$5.79B
| $45.7M | 0.84% |
772,389
+35,822
| +5% | +$2.21M |
2013 Q2
3 quarters
|
|
52
Cboe Global Markets
CBOE
$32.2B
| $44.6M | 0.82% |
788,098
-98,932
| -11% | -$5.31M |
2013 Q2
3 quarters
|
|
|
53
Meta Platforms (Facebook)
META
$1.88T
| $44.3M | 0.81% |
735,407
+664,407
| +936% | +$42.1M |
2013 Q2
3 quarters
|
|
54
Dover
DOV
$26.1B
| $43.2M | 0.79% |
654,921
-121,090
| -16% | -$7.53M |
2013 Q2
3 quarters
|
|
55
Affiliated Managers Group
AMG
$9.91B
| $42M | 0.77% |
210,051
-356
| -0.2% | -$69.9K |
2013 Q2
3 quarters
|
|
|
LNKD
56
DELISTED
LinkedIn Corporation
LNKD
| $41.7M | 0.77% |
225,500
-250,297
| -53% | -$51.3M |
2013 Q2
3 quarters
|
|
57
DELISTED
Coterra Energy
CTRA
| $37.2M | 0.68% |
1,097,692
-965,193
| -47% | -$35.6M |
2013 Q2
3 quarters
|
|
58
Elevance Health
ELV
$92.9B
| $36.9M | 0.68% |
371,130
+6,077
| +2% | +$550K |
2013 Q3
2 quarters
|
|
59
Polaris
PII
$3.04B
| $36.7M | 0.67% |
262,821
+30,168
| +13% | +$4.07M |
2013 Q2
3 quarters
|
|
|
MON
60
DELISTED
Monsanto Co
MON
| $34.4M | 0.63% |
302,406
+168,429
| +126% | +$18.7M |
2013 Q2
3 quarters
|
|
|
SLXP
61
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $33.6M | 0.62% |
324,479
+305,017
| +1,567% | +$31.2M |
2013 Q4
1 quarter
|
|
|
FRC
62
DELISTED
First Republic Bank
FRC
| $32.8M | 0.6% |
606,707
+246,390
| +68% | +$12.7M |
2013 Q2
3 quarters
|
|
63
Rockwell Automation
ROK
$46.9B
| $32.4M | 0.59% |
259,829
+68,544
| +36% | +$8.14M |
2013 Q2
3 quarters
|
|
64
Ecolab
ECL
$81.5B
| $32.3M | 0.59% |
299,212
-14,241
| -5% | -$1.49M |
2013 Q2
3 quarters
|
|
65
Genuine Parts
GPC
$18.4B
| $31.4M | 0.58% |
361,113
+3,459
| +1% | +$292K |
2013 Q2
3 quarters
|
|
66
Brookfield
BN
$82.2B
| $30.3M | 0.56% |
3,169,459
+37,387
| +1% | +$341K |
2013 Q2
3 quarters
|
|
|
DNKN
67
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $30.3M | 0.56% |
603,365
+3,820
| +0.6% | +$188K |
2013 Q2
3 quarters
|
|
68
Johnson & Johnson
JNJ
$610B
| $29.9M | 0.55% |
303,876
+241,309
| +386% | +$22.4M |
2013 Q2
3 quarters
|
|
69
Manhattan Associates
MANH
$13.2B
| $28.2M | 0.52% |
804,262
+754,326
| +1,511% | +$26.3M |
2013 Q3
2 quarters
|
|
70
Yelp
YELP
$1.11B
| $27.5M | 0.51% |
357,508
+146,910
| +70% | +$12.4M |
2013 Q3
2 quarters
|
|
|
71
Methanex
MEOH
$4.92B
| $26.7M | 0.49% |
+417,711
| New | +$26.4M |
2014 Q1
0 quarters
|
|
72
Amgen
AMGN
$235B
| $25.4M | 0.47% |
205,975
+203,730
| +9,075% | +$24.7M |
2013 Q2
3 quarters
|
|
73
US Bancorp
USB
$89.4B
| $24.1M | 0.44% |
561,755
+9,844
| +2% | +$405K |
2013 Q2
3 quarters
|
|
74
Insulet
PODD
$9.62B
| $23.5M | 0.43% |
494,714
+486,549
| +5,959% | +$21.5M |
2013 Q2
3 quarters
|
|
75
Core Laboratories
CLB
$449M
| $22.5M | 0.41% |
113,163
+36,231
| +47% | +$6.84M |
2013 Q2
3 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2014 Portfolio in Review
As of Q1 2014, Geneva Advisors held 760 positions worth $5.44B, up 0.47% from $5.42B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geneva Advisors's Q1 2014 filing shows 155 new, 313 increased, 140 reduced and 45 closed positions. Its largest new stake was Methanex: 417,711 shares worth $26.7M. The largest sale was LKQ Corp, an estimated $54.6M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Geneva Advisors's largest Q1 2014 buy was Methanex: 417,711 shares worth $26.7M.
- Geneva Advisors added most to JPMorgan Chase in Q1 2014, an estimated $51.9M increase.
- Geneva Advisors's biggest Q1 2014 reduction was LKQ Corp, cutting an estimated $54.6M.
- Geneva Advisors fully exited QIWI PLC in Q1 2014, selling an estimated $26.1M.
- Geneva Advisors's ten largest holdings make up 19% of its $5.44B portfolio in Q1 2014.
- Geneva Advisors opened 155 new positions and closed 45 in Q1 2014.
- Geneva Advisors's portfolio value rose 0.47% quarter-over-quarter to $5.44B.
Based on Geneva Advisors's 13F filing for Q1 2014, filed 5 May 2014.